Researchers at South Tees Hospitals NHS Foundation Trust and the University of Sunderland have found that fatigue, myalgia, headaches and pain were experienced by 25-30% healthcare workers receiving the first dose of the Pfizer/BioNTec COVID vaccine. Participants were more likely to suffer side effects if they had previously had COVID-19 infection.
A scientific and medical team led by Newcastle University, UK, have demonstrated that the gene, HLA-DRB1*04:01, is found three times as often in people who are asymptomatic. This suggests that people with this gene have some level of protection from severe COVID.
The NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, shown from interim analysis of its Phase III study data, including effectiveness against the new variants of concern.
Durham Tees Valley Research Alliance has joined the fight against coronavirus by recruiting COVID-19 patients to participate in a ground-breaking new study.
The Research and Innovation Team at South Tees Hospitals NHS Foundation Trust recruited a record number of patients to take part in clinical trials last year. In 2017/18 the team recruited 3,758 patients to clinical research trials – a 9% increase on the previous year. The impressive figure places South Tees among the top 10% of all NHS trusts across the country when it comes to research recruitment.